Fumarates, a new treatment option for therapy‐resistant hidradenitis suppurativa: a prospective open‐label pilot study

E-ISSN： 1365-2133|172|3|828-829

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.172, Iss.3, 2015-03, pp. : 828-829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Canakinumab for the Treatment of Children With Colchicine‐Resistant Familial Mediterranean Fever: A 6‐Month Open‐Label, Single‐Arm Pilot Study

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3241-3243

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment

Urologia Internationalis, Vol. 98, Iss. 1, 2016-09 ,pp. : 79-84

Karger

Access to resources Recommend Favorite

A pilot study of fatigue in patients with hidradenitis suppurativa

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e42-e43

John Wiley & Sons Inc

Access to resources Recommend Favorite

New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single‐blind, randomized, comparative study

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 2, 2015-03 ,pp. : 116-122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Repetitive dihydroergotamine nasal spray for treatment of refractory headaches: an open-label pilot study

By Weintraub James

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2031-2036

Informa Healthcare

Access to resources Recommend Favorite